pbm glp-1 news 📢 CMS Announces Medicare Bridge Demonstration Program The Centers for Medicare & Medicaid Services (CMS) has released new guidance on the Medicare GLP-1 Bridge, a short-term demonstration program running July 1 –December Alarming rise in weight loss

Modes of resistance to anti-angiogenic therapy

KLOW 80mg is a four-compound research blend containing GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) 80mg of total net peptide in one lyophilized vial, studied for multi-pathway tissue-repair and anti-inflammatory research

Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study

This review synthesizes findings from randomized controlled trials, open-label studies, and observational research examining ALC use and clinical outcomes in adults treated with ALC in MDD and BD